SMS Pharmaceuticals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals has filed a statement with NSE disclosing any deviation or variation in the use of proceeds from a prior fund-raising activity (such as a public issue, rights issue, or preferential issue), as required under SEBI Regulation 32. This regulation mandates companies to report to the exchange if the actual use of funds differs from the purpose stated in the original offer document. The specific details of the deviation — including the amount involved, the original purpose, and the revised use — are not visible in the headline and would be in the attached document. Investors should review the full filing to understand the nature and extent of the variation.
Deviation filings under Reg. 32 are routine compliance disclosures, but a significant or unexplained variation from stated fund-use plans may raise concerns about capital allocation discipline. Shareholders should check the full document to assess whether the deviation is material or benign.